AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
21:18
A Romanian worker died in Italy after falling from scaffolding at a construction site in the province of L’Aquila
21:07
Police detained a 55-year-old man from Hîncești, suspected of sexually abusing a nine-year-old girl
20:56
Kimberly Guilfoyle rejects the allegations and suggests that her term as ambassador to Greece is nearing its end
20:53
An archaeological expedition is investigating a mysterious object in the Pacific that could be Amelia Earhart’s missing airplane
20:43
Ministry of Education: 4,615 candidates passed the test for director positions
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
